EISENBERG GLENN A 4

4 · LABCORP HOLDINGS INC. · Filed Dec 4, 2024

Form 4

Period: 2024-12-02

Executive Vice President

Transactions

Exercise/Conversion
Common Stock
2024-12-02$221.67/sh+2,788$618,016→ 43,000 total
Sale
Common Stock
2024-12-02$240.43/sh−11,711$2,815,651→ 31,289 total
Exercise/Conversion
Non-qualified Stock Options
2024-12-02−8,923→ 0 total
Exercise: $209.25From: 2022-02-02Exp: 2031-02-01→ Common Stock (8,923 underlying)
Exercise/Conversion
Common Stock
2024-12-02$209.25/sh+8,923$1,867,138→ 40,212 total
Exercise/Conversion
Non-qualified Stock Options
2024-12-02−2,788→ 5,577 total
Exercise: $221.67From: 2024-02-07Exp: 2033-02-06→ Common Stock (2,788 underlying)

Footnotes (5)

[F1]The price of $240.4279 per share represents a weighted average of sales prices ranging from $240.015 to $240.94 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
[F2]Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. Amended and Restated 2016 Omnibus Incentive Plan.
[F3]Represents amounts automatically adjusted based on the final adjustment ratio applied to equity awards in connection with the spin-off of Fortrea Holdings Inc. ("Fortrea") by Labcorp Holdings Inc. ("LHI"), calculated pursuant to the terms of the Employee Matters Agreement by and between LHI and Fortrea.
[F4]The option vested in three equal annual installments beginning on the date reflected in this column.
[F5]The option vests in three equal annual installments beginning on the date reflected in this column.

Documents

1 file